Canopy Growth (TSE: WEED) had its price target hoisted by research analysts at Eight Capital from C$40.00 to C$50.00 in a report issued on Friday. Eight Capital’s target price suggests a potential upside of 27.00% from the stock’s previous close.
Several other research firms also recently commented on WEED. Pi Financial reiterated a “top pick” rating on shares of Canopy Growth in a research note on Thursday, April 5th. Canaccord Genuity lifted their price objective on shares of Canopy Growth from C$26.50 to C$27.50 in a research note on Wednesday, May 2nd. Finally, Cormark lifted their price objective on shares of Canopy Growth from C$25.00 to C$33.00 in a research note on Thursday, June 28th.
Shares of WEED opened at C$39.37 on Friday. Canopy Growth has a twelve month low of C$7.73 and a twelve month high of C$48.72.
Canopy Growth Company Profile
Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc and changed its name to Canopy Growth Corporation in September 2015.
Receive News & Ratings for Canopy Growth Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Canopy Growth and related companies with MarketBeat.com’s FREE daily email newsletter.
Credit: www.baseballdailydigest.com
